Gender and the Genome

About This Journal:

  • Print This Page
  • Subscribe to an RSS Feed
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Gender and the Genome

Editor-in-Chief: Marianne J. Legato, MD, PhD (hon. c.), FACP

ISSN: 2470-2897 • Online ISSN: 2470-2900 • Published Quarterly

Current Volume: 1

As of December 2017, Mary Ann Liebert, Inc. is no longer the publisher of Gender and the Genome, The Official Journal of the Foundation for Gender-Specific Medicine. For any inquiries concerning the journal, please contact Dr. Marianne J. Legato at the Foundation for Gender-Specific Medicine at 903 Park Avenue, Suite 2A, New York, NY 10075, Phone (212) 737-5663.

Featured Press Releases and Editorial Content

  • Sex Now Needs to Be Included as a Biological Variable in NIH-Funded Research, But How?...Read More
  • The Foundation for Gender-Specific Medicine and Gender and the Genome (Mary Ann Liebert, Inc., publishers) Announce the Robert S. Birch $25,000 Award Competition for the Best Original Research Paper or Commentary...Read More
  • Science and Legal Experts Debate Future Uses and Impact of Human Genome Editing in Gender and the Genome...Read More
  • Groundbreaking Journal, Gender and the Genome, To Launch in Summer 2016...Read More


Gender and the Genome, a new peer-reviewed journal, explores how the new science of the 21st century is profoundly influenced by biological sex. Through evidence-based original research, reviews, perspectives, and commentaries, the Journal illuminates the impact of biological sex on technology and its effects on human life. The Journal’s international editorial board is comprised of the most forward-thinking leaders in gender-specific medicine to engage the community of molecular biologists, engineers, ethicists, anthropologists, and legal experts in a dialogue about the nature and implications of 21st century technology.

Gender and the Genome coverage includes:

  • Sex-specific differences in genomic, cellular, tissue, and whole animal function
  • New life forms generated by synthetic biology
  • Technological advances meant to enhance the function in humans, whether compromised by disease/injury or in normal individuals
  • Manufacture and usefulness of robotic devices
  • Commentaries by ethicists, theologians, anthropologists, epidemiologists, and sociologists/social scientists on the achievements of 21st century science to alter the genome, create new life forms, and develop technologically enhanced humans

Gender and the Genome is under the editorial leadership of Editor-in-Chief Marianne J. Legato, MD, PhD (hon. c.), FACP, Emerita Professor of Clinical Medicine, Columbia University; Adjunct Professor of Medicine, Johns Hopkins School of Medicine; and Founder, Foundation for Gender-Specific Medicine; and other leading investigators.

Audience: Molecular biologists, epidemiologists, immunologists, engineers, ethicists, anthropologists, sociologists/social scientists, and legal experts, among others.

Society Affiliation

The Official Journal of The Foundation for Gender-Specific Medicine


The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    DNA and Cell Biology

    DNA and Cell Biology

    Combining mechanistic and clinical studies from multiple systems in a single resource, the Journal delivers authoritative, peer-reviewed reporting on the latest research in the field of molecular biology.

    Human Gene Therapy

    Human Gene Therapy

    The definitive rapid-publication journal covering all aspects of gene therapy through original investigations into the transfer and expression of genes in mammals, with in-depth coverage of DNA, RNA, and cell therapies.

    Nucleic Acid Therapeutics

    Nucleic Acid Therapeutics

    formerly Oligonucleotides

    Focuses on cutting-edge research and applications to find and examine new approaches using nucleic acids in therapeutics including oligonucleotides, gene modification, aptamers, RNA nanoparticles, ribozymes, and more.

    Cellular Reprogramming

    Cellular Reprogramming

    Cutting-edge techniques and the latest high-quality research on the etiology, development, and potential treatment of various diseases through reprogramming cellular mechanisms.

Browse All Publications »